Core Viewpoint - Huajian Medical (01931) has seen a significant stock price increase, with a cumulative rise of over 500% since July 14, and a current price of 11.95 HKD, reflecting a 19.5% increase at the time of reporting [1] Group 1: Strategic Developments - On August 8, Huajian Medical announced the launch of its "Global Enhanced Ethereum (ETH) Treasury" strategy and formed a global strategic partnership with HashKey Group [1] - A signing ceremony for the global strategic cooperation and the upgrade of the Global Enhanced Ethereum (ETH) Treasury strategy was held on August 11 at HashKey's office in Hong Kong [1] Group 2: Collaborations and Investments - On July 30, Huajian Medical signed a strategic cooperation framework agreement with BGI Win to establish the "Huajian BGI Win Innovative Drug Intellectual Property Tokenization Fund" [1] - This fund aims to invest in Huajian Medical's "NewCo+RWA" Web3 exchange ecosystem projects in Hong Kong, the United States, and other locations [1] - BGI Win, initiated by BGI Genomics, is a corporate venture capital entity with extensive experience and resources in innovative medical and pharmaceutical investments [1]

Core Viewpoint - Huajian Medical Holdings Limited (01931) has officially launched the "Global Enhanced Ethereum (ETH) Vault" strategy and entered into a global strategic partnership with HashKey Group, marking a significant step into the Web3 financial sector for the healthcare industry [1][4]. Group 1: Strategic Collaboration - The partnership will involve signing a global strategic cooperation framework agreement, leveraging HashKey Group's fully licensed compliance ecosystem to provide Huajian Medical with comprehensive digital asset management services [1]. - The collaboration will focus on large-scale Ethereum (ETH) trading execution and cost optimization, global market liquidity support, and exploring the tokenization of real-world assets (RWA) related to innovative medical drug intellectual property [1][4]. Group 2: Global Enhanced Ethereum Vault Strategy Upgrade - The upgrade of the "Global Enhanced Ethereum (ETH) Vault" will be announced, aiming to create a safer, more efficient, and compliant digital asset service system, providing innovative asset allocation paths for global investors [2]. Group 3: Industry Impact - This collaboration is expected to reshape the financial infrastructure of the healthcare industry, injecting real economic value into the digital asset sector and promoting the globalization of innovative drug research and development [6]. - By utilizing blockchain technology's traceability and transparency, the partnership aims to establish a trust bridge between medical intellectual property and digital assets, offering new pathways for global investors to engage in medical innovation [6]. Group 4: Event Details - The signing ceremony and strategic upgrade announcement will take place on August 11, 2025, at 14:00 in Hong Kong [7]. Group 5: Company Background - Huajian Medical focuses on innovative drug research and development, digital healthcare solutions, and global resource integration, aiming to enhance the accessibility of medical services through technology [8]. - HashKey Group is a leading blockchain ecosystem platform in Asia, holding a virtual asset trading platform license from the Hong Kong Securities and Futures Commission, providing compliant digital asset trading, custody, and asset management services [8].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1931） 自願性公告 打 造「全 球 增 強 版 以 太 坊（ETH）金 庫」、升 維 公 司 全 球 戰 略、為 生 態 參 與 者創造價值 本 公 告 由 華 檢 醫 療 控 股 有 限 公 司（「本公司」或「華檢醫療」，連 同 其 附 屬 公 司 統 稱「本集團」）董 事 會（「董事會」）自 願 作 出，旨 在 向 股 東、潛 在 投 資 者 及 市 場 各 方 全 面 闡 述 本 集 團 最 新 戰 略 升 級 暨 升 維 舉 措－經 董 事 會 決 議 通 過，本 集 團 正 式 啟 動「具 備 下 行 保 護 機 制 的 全 球 增 強 版 以 太 坊（ETH）金 庫」戰 略（「以 太 坊（ETH） 金庫戰略」） ...